Pretraga rezultata za izvrsnost 2025




IBI: AN992; Nađa Grozdanić Stanisavljević***, naučni saradnik, Institut za onkologiju i radiologiju Srbije u Beogradu; Polje: prirodno-matematičke i medicinske nauke; Period: 2018-2024;


eNauka profil: rp02500; ORCID: 0000-0002-2543-0838;


WOS indikatori: NR = 27; TC = 369; HIndex = 12;


eNauka WOS indikatori: NR = 32; TC = 376; HIndex = 12 ;


Lista A broj bodova: 59.17198 (618) 32.0%; Lista B broj bodova: 234.5331 (618) 5.0%; Lista C broj bodova: 0.000 (0) nan%; Lista A broj bodova kolaboracije: 0.000 (0) nan%; Lista B broj bodova kolaboracije: 0.000 (0) nan%;

Statistika svih rezultata

StatistikaUkupno2013-20242015-20242018-20242020-2024
Broj rezultata272216106
Broj citata369289
Broj M bodova83.008376.0055
Normirani broj citata298.39234.53
Normirani broj M bodova rezultata kategorije M21a++M21a+M21+M22+M23+M2465.3365.3359.1740.67
Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M410.000.000.000.00
Normirani broj M bodova rezultata kategorije M11+M12+M13+M14+M41+M420.000.000.000.00
Normirani broj M bodova rezultata kategorije M510.000.000.000.00
Normirani broj M bodova rezultata kategorije M43+M440.000.000.000.00

Statistika rezultata nastalih u medunarodnim kolaboracijama

StatistikaUkupno2013-20242015-20242018-20242020-2024
Broj rezultata sa 20 i više autora00000
Broj citata rezultata sa 20 i više autora00
Broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora0.0000.000
Normirani broj citata rezultata sa 20 i više autora0.000.00
Normirani broj M bodova rezultata M21a++M21a+M21+M22+M23 sa 20 i više autora0.000.00

Rezultati

RBIBIGodinaKatTipVrstaReferencaTCTCPBANBBNTCNaslovAutori
1.AN9922012EBMC IMMUNOLOGY Vol. 13 (): #48 - (7), (DOI: 10.1186/1471-2172-13-48) AUG 21 2012WOS19161506.1538Serum activity of DPPIV and its expression on lymphocytes in patients with melanoma and in people with vitiligoMatic I, Dordic M, Grozdanic N, Damjanovic A, Kolundzija B, Eric-Nikolic A, Dzodic R, Sasic M, Nikolic S, Dobrosavljevic D, Raskovic S, Andrejevic S, Gavrilovic D, Cordero O, Juranic Z
2.AN9922012EBMC COMPLEMENTARY AND ALTERNATIVE MEDICINE Vol. 12 (): #109 - (8), (DOI: 10.1186/1472-6882-12-109) JUL 26 2012WOS16101603.5714Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligoDordic M, Matic I, Filipovic-Ljeskovic I, Dzodic R, Sasic M, Eric-Nikolic A, Vuletic A, Kolundzija B, Damjanovic A, Grozdanic N, Nikolic S, Pralica J, Dobrosavljevic D, Raskovic S, Andrejevic S, Juranic Z
3.AN9922013EARCHIVES OF BIOLOGICAL SCIENCES Vol. 65 (1): # 65 - 70 (6), (DOI: 10.2298/ABS1301065M) 2013WOS43703.0000ANTIPROLIFERATIVE EFFECTS OF SOME MEDICINAL PLANTS ON HELA CELLSCenic-Milosevic D, Tambur Z, Bokonjic D, Ivancajic S, Stanojkovic T, Grozdanic N, Juranic Z
4.AN9922013EARCHIVES OF BIOLOGICAL SCIENCES Vol. 65 (3): # 885 - 891 (7), (DOI: 10.2298/ABS1303885M) 2013WOS44902.8571ANTIPROLIFERATIVE EFFECTS OF CAMELLIA SINENSIS, FRANGULA ALNUS AND ROSMARINUS OFFICINALISCenic-Milosevic D, Tambur Z, Ivancajic S, Bokonjic D, Cukovic A, Stanojkovic T, Grozdanic N, Kulisic Z, Juranic Z
5.AN9922013ELEUKEMIA & LYMPHOMA Vol. 54 (12): # 2701 - 2706 (6), (DOI: 10.3109/10428194.2013.782611) DEC 2013WOS331701.0000Dipeptidyl peptidase IV: serum activity and expression on lymphocytes in different hematological malignanciesMatic I, Dordevic M, Dordic M, Grozdanic N, Damjanovic A, Kolundzija B, Vidovic A, Bila J, Ristic S, Mihaljevic B, Tomin D, Milanovic N, Ristic D, Puric M, Gavrilovic D, Cordero O, Juranic Z
6.AN9922014EARCHIVES OF BIOLOGICAL SCIENCES Vol. 66 (2): # 705 - 712 (8), (DOI: 10.2298/ABS1402705M) 2014WOS44704.0000ANTIPROLIFERATIVE EFFECTS OF TANACETI PARTHENI, HYPERICUM PERFORATUM AND PROPOLIS ON HELA CELLSCenic-Milosevic D, Tambur Z, Ivancajic S, Stanojkovic T, Grozdanic N, Kulisic Z, Juranic Z
7.AN9922014EIMMUNOLOGICAL INVESTIGATIONS Vol. 43 (5): # 504 - 516 (13), (DOI: 10.3109/08820139.2014.892509) 2014WOS441102.2222Immunoreactivity to food antigens in patients with chronic urticariaRaskovic S, Matic I, Dordic M, Damjanovic A, Kolundzija B, Grozdanic-Stanisavljevic N, Besu I, Jovicic Z, Bijelic B, Jankovic L, Juranic Z
8.AN9922014EDIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES Vol. 9 (2): # 869 - 880 (12), (DOI: ) APR-JUN 2014WOS109709.0000ANTIOXIDANT, ANTIPLATELET AND CYTOTOXIC ACTIVITY OF EXTRACT OF CYSTOSEIRA AMENTACEA FROM THE COAST OF MONTENEGRO (SOUTH-EAST ADRIATIC SEA)Stanojkovic T, Konic-Ristic A, Kljajic Z, Grozdanic-Stanisavljevic N, Srdic-Rajic T, Zdunic G, Savikin K
9.AN9922016ECHEMISTRY & BIODIVERSITY Vol. 13 (4): # 466 - 476 (11), (DOI: 10.1002/cbdv.201500151) APR 2016WOS17158012.5000Chemical Composition, Antimicrobial and Cytotoxic Activity of Heracleum verticillatum PANCIC and H. ternatum VELEN. (Apiaceae) Essential OilsUsjak L, Petrovic S, Drobac M, Sokovic M, Stanojkovic T, Ciric A, Grozdanic N, Niketic M
10.AN9922016EINDUSTRIAL CROPS AND PRODUCTS Vol. 79 (): # 110 - 115 (6), (DOI: 10.1016/j.indcrop.2015.10.030) JAN 2016WOS48388031.6667Antibacterial and cytotoxic activities of wild mushroom Fomes fomentarius (L.) Fr., PolyporaceaeKolundzic M, Grozdanic N, Dodevska M, Milenkovic M, Sisto F, Miani A, Farronato G, Kundakovic T
11.AN9922016EINTERNATIONAL JOURNAL OF MEDICINAL MUSHROOMS Vol. 18 (6): # 469 - 476 (8), (DOI: 10.1615/IntJMedMushrooms.v18.i6.10) 2016WOS76805.0000Antimicrobial and Cytotoxic Activities of the Sulphur Shelf Medicinal Mushroom, Laetiporus sulphureus (Agaricomycetes), from SerbiaKolundzic M, Grozdanic N, Stanojkovic T, Milenkovic M, Dinic M, Golic N, Kojic M, Kundakovic T
12.AN9922017EJOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY Vol. 32 (1): # 298 - 303 (6), (DOI: 10.1080/14756366.2016.1250754) 2017WOS21197019.0000α-Glucosidase inhibitory activity and cytotoxic effects of some cyclic urea and carbamate derivativesPopovic-Djordjevic J, Jevtic I, Grozdanic N, Segan S, Zlatovic M, Ivanovic M, Stanojkovic T
13.AN9922017ECURRENT PHARMACEUTICAL BIOTECHNOLOGY Vol. 18 (15): # 1264 - 1272 (9), (DOI: 10.2174/1389201019666180410112439) 2017WOS23217021.0000Fruit Wines Inhibitory Activity Against α-GlucosidaseCakar U, Grozdanic N, Petrovic A, Pejin B, Nastasijevic B, Markovic B, Dordevic B
14.AN9922017EFARMACIA Vol. 65 (5): # 731 - 740 (10), (DOI: ) SEP-OCT 2017WOS1110808.3333ANTI α-GLUCOSIDASE, ANTITUMOUR, ANTIOXIDATIVE, ANTIMICROBIAL ACTIVITY, NUTRITIVE AND HEALTH PROTECTIVE POTENTIAL OF SOME SEAWEEDS FROM THE ADRIATIC COAST OF MONTENEGROMilovic S, Kundakovic T, Macic V, Stankovic J, Grozdanic N, Duricic I, Stankovic I, Stanojkovic T
15.AN9922018M21aEArticleFRONTIERS IN IMMUNOLOGY Vol. 8 (): #1886 - (8), (DOI: 10.3389/fimmu.2017.01886) JAN 4 2018WOS9987.50007.5000Peripheral White Blood Cell Subsets in Metastatic Colorectal Cancer Patients Treated with Cetuximab: The Potential Clinical RelevanceMatic I, Kolundzija B, Damjanovic A, Spasic J, Radosavljevic D, Crnogorac M, Grozdanic N, Juranic Z
16.AN9922018M21EArticleFOOD BIOSCIENCE Vol. 25 (): # 1 - 7 (7), (DOI: 10.1016/j.fbio.2018.06.009) OCT 2018WOS373476.000034.0000Impact of vinification procedure on fruit wine inhibitory activity against α-glucosidaseCakar U, Grozdanic N, Pejin B, Vasic V, Cakar M, Petrovic A, Djordjevic B
17.AN9922018M22EArticleARCHIV DER PHARMAZIE Vol. 351 (5): #e1700308 - (13), (DOI: 10.1002/ardp.201700308) MAY 2018WOS222083.125016.6667Biological evaluation of selected 3,4-dihydro-2(1H)-quinoxalinones and 3,4-dihydro-1,4-benzoxazin-2-ones: Molecular docking studyPetronijevic J, Jankovic N, Stanojkovic T, Joksimovic N, Grozdanic N, Vranes M, Tot A, Bugarcic Z
18.AN9922019M23EArticleACTA POLONIAE PHARMACEUTICA Vol. 76 (5): # 833 - 844 (12), (DOI: 10.32383/appdr/108920) SEP-OCT 2019WOS101081.87508.3333SEASONAL VARIATION IN BIOPHARMACEUTICAL ACTIVITY AND FATTY ACID CONTENT OF ENDEMIC FUCUS VIRSOIDES ALGAE FROM ADRIATIC SEAGrozdanic N, Zdunic G, Savikin K, Duricic I, Kosanic M, Macic V, Matic I, Stanojkovic T
19.AN9922020M23EArticleJOURNAL OF BUON Vol. 25 (2): # 1219 - 1229 (11), (DOI: ) MAR-APR 2020WOS1513111.66677.2222Fucus spiralis extract and fractions: anticancer and pharmacological potentialsGrozdanic N, Djuricic I, Kosanic M, Zdunic G, Savikin K, Etahiri S, Assobhei O, Benba J, Petovic S, Matic I, Stanojkovic T
20.AN9922022M21aEArticleHORTICULTURAE Vol. 8 (11): #1053 - (17), (DOI: 10.3390/horticulturae8111053) NOV 2022WOS3016712.000016.0000Polyphenolic Profile, Antioxidant and Antidiabetic Potential of Medlar (Mespilus germanica L.), Blackthorn (Prunus spinosa L.) and Common Hawthorn (Crataegus monogyna Jacq.) Fruit Extracts from SerbiaStankovic J, Micanovic N, Grozdanic N, Kostic A, Gasic U, Stanojkovic T, Popovic-Djordjevic J
21.AN9922022M21aEArticlePHARMACEUTICS Vol. 14 (10): #2254 - (12), (DOI: 10.3390/pharmaceutics14102254) OCT 2022WOS1510107.50006.2500Synthesis, Characterization, and Biological Evaluation of Tetrahydropyrimidines: Dual-Activity and Mechanism of ActionMilovic E, Jankovic N, Petronijevic J, Joksimovic N, Kosanic M, Stanojkovic T, Matic I, Grozdanic N, Klisuric O, Stefanovic S
22.AN9922022M21EArticleMOLECULES Vol. 27 (24): #9048 - (12), (DOI: 10.3390/molecules27249048) DEC 2022WOS84124.00002.0000Evaluation of In Vitro Cytotoxic Potential of Avarol towards Human Cancer Cell Lines and In Vivo Antitumor Activity in Solid Tumor ModelsStanojkovic T, Filimonova M, Grozdanic N, Petovic S, Shitova A, Soldatova O, Filimonov A, Vladic J, Shegay P, Kaprin A, Ivanov S, Nikitovic M
23.AN9922023M21aEArticlePHARMACEUTICALS Vol. 16 (1): #49 - (20), (DOI: 10.3390/ph16010049) JAN 2023WOS1810107.50006.2500Synthesis and Cytotoxicity Evaluation of Novel Coumarin-Palladium(II) Complexes against Human Cancer Cell LinesAvdovic E, Antonijevic M, Simijonovic D, Roca S, Topic D, Grozdanic N, Stanojkovic T, Radojevic I, Vojinovic R, Markovic Z
24.AN9922024M21EArticlePOLYMERS Vol. 16 (5): #688 - (20), (DOI: 10.3390/polym16050688) MAR 2024WOS9168.00001.0000Stabilization of Black Locust Flower Extract via Encapsulation Using Alginate and Alginate-Chitosan MicroparticlesBoskov I, Savic I, Stanisavljevic N, Kundakovic-Vasovic T, Selgrad J, Gajic I
25.AN9922025EASIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 14 (9): # - (8), (DOI: 10.1002/ajoc.202500315) SEP 2025WOS00700.0000Exploiting the Versatile Reactivity of Aryldiazonium Tetrafluoroborate Salts in the Synthesis of New Isochromene-Fused CF3-Substituted Pyrazoles with Anticancer PotentialAndrijevic A, Markovic M, Selakovic M, Grozdanic N, Stanojkovic T, Nikolic A, Opsenica I
26.AN9922025EJOURNAL OF MOLECULAR STRUCTURE Vol. 1321 (): #140075 - (10), (DOI: 10.1016/j.molstruc.2024.140075) FEB 5 2025WOS20700.0000Synthesis, antimicrobial, anticancer activity, 3D QSAR, ADMET properties, and in silico target fishing of novel N,N-disubstituted chloroacetamidesBogdanovic A, Marinkovic A, Stanojkovic T, Grozdanic N, Janakiev T, Cvijetic I, Petrovic S
27.AN9922025EJOURNAL OF MOLECULAR STRUCTURE Vol. 1332 (): #141680 - (15), (DOI: 10.1016/j.molstruc.2025.141680) JUN 15 2025WOS30700.0000Twisted amides based on the spirohydantoin scaffold as potential anticancer agentsLazic A, Surucic R, Stanisavljevic N, Popovic-Djordjevic J, Banjac N, Stanojkovic T, Trisovic N

27. 04. 2026.; 00:10:03; Trajanje procesiranja: 0.025 s


Legenda:

RB - redni broj rezultata
IBI - identifikacioni broj istraživača
Godina - godina u kojoj je rezultat publikovan (isključivo sa kompletnom paginacijom)
Kat - kategorija rezulata
Tip - tip rezultata (teorijski, simulacioni ili eksperimentalni)
Vrsta - vrsta rezultata
Referenca - referenca rezultata (bez autora i naslova rezultata) sa direktnim linkom na rezultat (ako ima DOI broj), sa linkom na zapis u eNauci ili WOS
TC - ukupan broj citata rezulata na dan 31. 1. 2026. godine
TCP - ukupan broj citata rezultata u periodu 2015-2024
BA - broj autora na rezultatu
NBB - normirani broj bodova rezultata
NTC - normirani broj citata rezultata u periodu 2015-2024
Naslov - naslov rezultata
Autori - spisak svih autora ili najviše prvih 30 autora


Primer:

Primer normiranja broja M poena i broja citata ostvarenih na jednom rezultatu: eksperimentalni rad sa 11 autora u časopisu kategorije M21a+ koji je publikovan 2020. godine, citiran je 65 puta, od čega 55 puta u periodu 2015-2024. godine.

Normirani broj M poena koje istraživač ostvaruje na rezultatu je 20/(1+0.2*(11-10))=16.6667 a normirani broj citata je 55/(1+0.2*(11-10))=45.8333.

Ukupan broj ostaverinih bodova utvrđuje se na naznačenom periodu za sabiranje normiranih M poena svakog istraživača i u periodu za određivanje ukupnog broja normiranih citata (2015-2024).